By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sucampo Pharmaceuticals, Inc. 

4733 Bethesda Avenue
Suite 450
Bethesda  Maryland  20814  U.S.A.
Phone: 301-961-3400 Fax: 301-961-3440


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Sucampo Pharmaceuticals, Inc. (SCMP) Reports Fourth Quarter And Full Year 2014 Financial Results And Corporate Update 3/4/2015 8:27:05 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Webcast Of Its Presentation At The 27th Annual ROTH Conference 3/3/2015 8:42:51 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Webcast Of Its Presentation At The 2015 Cowen and Company Healthcare Conference 2/23/2015 7:35:59 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Fourth Quarter And Full Year 2014 Earnings Call 2/18/2015 7:48:38 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Resolution Of Par Pharmaceutical, Inc.'s ANDA For RESCULA 2/12/2015 7:18:10 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Webcast Of Its Presentation At The 2015 Leerink Global Healthcare Conference 2/5/2015 1:18:31 PM
Sucampo Pharmaceuticals, Inc. (SCMP) Appoints Andrew Smith, FCMA, CGMA As CFO 2/2/2015 10:12:58 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Release: AMITIZA® (Lubiprostone) Mutual Recognition Procedure Closes With Recommendation For Approval In European Countries 1/30/2015 7:34:00 AM
Robert J. Spiegel, M.D., FACP Joins Sucampo Pharmaceuticals, Inc. (SCMP)'s Board Of Directors 1/21/2015 7:38:52 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Acceptance Of New Drug Submission For AMITIZA® (Lubiprostone) By Health Canada 12/31/2014 7:07:59 AM
12345678910...
//-->